Publications 2018

1. Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study.  Hatleberg CI,  Ryom L,  El-Sadr W,  Mocroft A, Reiss P, De Wit S, Dabis F, Pradier C, d’Arminio Monforte A, Kovari H, Law, M, Lundgren JD, Sabin C, On behalf of the Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group.
J Int AIDS Soc. 2018;21(3). Abstract

2. Abacavir use and risk of recurrent myocardial infarction.Sabin CA, Ryom L, d'Arminio Monforte A, Hatleberg CI, Pradier C, El-Sadr W, Kirk O, Weber R, Phillips AN, Mocroft A, Bonnet F, Law M, de Wit S, Reiss P, Lundgren JD; D:A:D Study Group.
AIDS. 2018;32(1):79-88. Abstract

3 Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study. L Ryom, JD Lundgren, W El-Sadr, P Reiss, O Kirk, M Law, A Phillips, R Weber, E Fontas, A d’ Arminio Monforte, S de Wit, F Dabis, CI Hatleberg, C Sabin, A Mocroft. On behalf of the D:A:D Study group
Lancet HIV. 2018 Jun;5(6):e291-e300.  Abstract

4 Differences in virological and immunological risk factors for non-Hodgkin and Hodgkin lymphoma.
L Shepherd, L Ryom, M Law, C Ingrid Hatleberg, S de Wit, A d'Arminio Monforte, M Battegay, A Phillips, F Bonnet, P Reiss, C Pradier, A Grulich, C Sabin, J Lundgren, A Mocroft,
J Natl Cancer Inst. 2018;110(6):598-607.  Abstract


Associations between serum albumin and serious non-AIDS events among people living with HIV. A Ronit, CI Hatleberg, L Ryom, F Bonnet, W El-Sadr, P Reiss, R Weber, C Pradier, S De Witt, M Law, A d’Arminio Monforte, J Lundgren, A Mocroft, AN Phillips, C Sabin, for the D:A:D Study group
AIDS 2018. Abstract

2 Body Mass Index and the Risk of serious non-AIDS events and all cause mortality in treated HIV-positive individuals: D:A:D Cohort Analysis
AC Achhra, C Sabin, L Ryom, C Hatleberg, A d’Aminio Monforte, S de Wit, A Phillips, C Pradier, R Weber, P Reiss, W El-Sadr, F Bonnet, A Mocroft, J Lundgren, MG Law for the D:A:D study group
JAIDS 2018. Abstract

3 Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the D:A:D Study. CI Hatleberg, L Ryom, A d’Arminio Monforte, E Fontas, P Reiss, O Kirk, W El-Sadr, A Phillips, S de Wit, F Dabis, R Weber, M Law, JD Lundgren, C Sabin  On behalf of the Data collection of Adverse events of anti-HIV Drugs (D:A:D) Study Group
HIV Medicine

4 Cessation of Cigarette Smoking and the Impact on Cancer Incidence in HIV-positive Persons: The D:A:D Study. L Shepherd, L Ryom, M Law, K Petoumenos, C Ingrid Hatleberg, A d’Arminio Monforte, C Sabin, M Bower, F Bonne, P Reiss, S de Wit, C Pradier, R Weber, W el-Sadr, J Lundgren, A Mocroft. On behalf of the D:A:D Study group
Clin Infect Dis. 2018 [Epub ahead of print] Abstract